These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 686701

  • 1. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N, Aswapokee P, Fu KP, Neu HC.
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [Abstract] [Full Text] [Related]

  • 2. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1978 Apr; 13(4):657-64. PubMed ID: 248268
    [Abstract] [Full Text] [Related]

  • 3. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.
    Jones RN, Thornsberry C, Barry AL, Fuchs PC, Gavin TL, Gerlach EH.
    J Antibiot (Tokyo); 1977 Jul; 30(7):583-92. PubMed ID: 893227
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity and beta-lactamase stability of cefazaflur compared with those of beta-lactamase-stable cephalosporins.
    Aswapokee N, Neu HC.
    Antimicrob Agents Chemother; 1979 Mar; 15(3):444-6. PubMed ID: 313753
    [Abstract] [Full Text] [Related]

  • 5. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN, Fuchs PC, Gavan TL, Gerlach EH, Barry A, Thornsberry C.
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [Abstract] [Full Text] [Related]

  • 6. BL-S786 (ceforanide), a new parenteral cephalosporin: in vitro studies.
    Weaver SS, LeBlanc BM, Bodey GP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):318-22. PubMed ID: 426520
    [Abstract] [Full Text] [Related]

  • 7. Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1978 Apr; 13(4):584-8. PubMed ID: 666290
    [Abstract] [Full Text] [Related]

  • 8. In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):313-20. PubMed ID: 6605718
    [Abstract] [Full Text] [Related]

  • 9. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F, Misiek M, Pursiano TA, Buck RE, Chisholm DR, DeRegis RG, Tsai YH, Price KE.
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [Abstract] [Full Text] [Related]

  • 10. Cefatrizine activity compared with that of other cephalosporins.
    Neu HC, Fu KP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):209-12. PubMed ID: 426514
    [Abstract] [Full Text] [Related]

  • 11. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
    Matsubara N, Minami S, Muraoka T, Saikawa I, Mitsuhashi S.
    Antimicrob Agents Chemother; 1979 Dec; 16(6):731-5. PubMed ID: 316988
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD.
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
    Yu KW, Chin NX, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.
    Richmond MH, Wotton S.
    Antimicrob Agents Chemother; 1976 Aug; 10(2):219-22. PubMed ID: 791093
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.
    Shadomy S, Wagner G, Carver M.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821
    [Abstract] [Full Text] [Related]

  • 16. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 17. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S, Arai S, Miyamoto M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP, Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [Abstract] [Full Text] [Related]

  • 19. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
    Neu HC, Aswapokee N, Aswapokee P, Fu KP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518
    [Abstract] [Full Text] [Related]

  • 20. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.